Immunocore Ltd, Abingdon, Oxfordshire, UK.
Eur J Immunol. 2022 Apr;52(4):618-632. doi: 10.1002/eji.202149745. Epub 2022 Feb 13.
The nonpolymorphic class Ib molecule, HLA-E, primarily presents peptides from HLA class Ia leader peptides, providing an inhibitory signal to NK cells via CD94/NKG2 interactions. Although peptides of pathogenic origin can also be presented by HLA-E to T cells, the molecular basis underpinning their role in antigen surveillance is largely unknown. Here, we solved a co-complex crystal structure of a TCR with an HLA-E presented peptide (pHLA-E) from bacterial (Mycobacterium tuberculosis) origin, and the first TCR-pHLA-E complex with a noncanonically presented peptide from viral (HIV) origin. The structures provided a molecular foundation to develop a novel method to introduce cysteine traps using non-natural amino acid chemistry that stabilized pHLA-E complexes while maintaining native interface contacts between the TCRs and different pHLA-E complexes. These pHLA-E monomers could be used to isolate pHLA-E-specific T cells, with obvious utility for studying pHLA-E restricted T cells, and for the identification of putative therapeutic TCRs.
非多态性 Ib 类分子 HLA-E 主要呈递来自 HLA Ia 类前导肽的肽段,通过 CD94/NKG2 相互作用向 NK 细胞提供抑制信号。虽然源自病原体的肽段也可以被 HLA-E 呈递给 T 细胞,但它们在抗原监测中的作用的分子基础在很大程度上尚不清楚。在这里,我们解决了一个 TCR 与 HLA-E 呈递的肽段(pHLA-E)的共复合物晶体结构,该肽段来自细菌(结核分枝杆菌)来源,并且是第一个与来自病毒(HIV)来源的非规范呈递肽段的 TCR-pHLA-E 复合物。这些结构为开发一种使用非天然氨基酸化学引入半胱氨酸陷阱的新方法提供了分子基础,该方法稳定了 pHLA-E 复合物,同时保持了 TCR 与不同 pHLA-E 复合物之间的天然界面接触。这些 pHLA-E 单体可用于分离 pHLA-E 特异性 T 细胞,对于研究 pHLA-E 限制的 T 细胞以及鉴定潜在的治疗性 TCR 具有明显的用途。